• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名纹状体黑质变性患者的早期运动波动

Early Motor Fluctuations in a Patient with Striatonigral Degeneration.

作者信息

Yoshii Fumihito, Moriya Yusuke, Ohnuki Tomohide, Takahashi Wakoh, Ryo Masafuchi

机构信息

Department of Neurology, Tokai University Oiso Hospital, Oiso, Japan.

出版信息

Case Rep Neurol. 2016 Dec 13;8(3):243-250. doi: 10.1159/000453254. eCollection 2016 Sep-Dec.

DOI:10.1159/000453254
PMID:28101035
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5216213/
Abstract

We report a 44-year-old female with striatonigral degeneration (SND) who showed wearing-off oscillations after 4 months of levodopa treatment. The patient presented with asymmetric left-side dominant rigidity, and levodopa was effective at first. However, she began to show wearing-off oscillations of motor symptoms, which gradually worsened thereafter. Fluid-attenuated inversion recovery sequence magnetic resonance imaging (MRI) showed linear lateral putamen hyperintensities, and positron emission tomography (PET) studies using F-fluorodopa (FD) and C-N-methylspiperon (NMSP) showed a marked decrease of radioactivity in the right putamen, especially in the posterior putamen. The results of MRI and 2 PET studies with FD and NMSP were well consistent with the diagnosis of SND.

摘要

我们报告了一名44岁患有纹状体黑质变性(SND)的女性,她在左旋多巴治疗4个月后出现剂末波动。患者表现为以左侧为主的不对称性强直,左旋多巴起初有效。然而,她开始出现运动症状的剂末波动,此后逐渐加重。液体衰减反转恢复序列磁共振成像(MRI)显示壳核外侧呈线性高信号,使用F-氟多巴(FD)和C-N-甲基螺哌隆(NMSP)的正电子发射断层扫描(PET)研究显示右侧壳核放射性明显降低,尤其是壳核后部。MRI以及FD和NMSP的两项PET研究结果与SND的诊断高度一致。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb60/5216213/3fd4c7934d6a/crn-0008-0243-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb60/5216213/6245f0fa3fee/crn-0008-0243-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb60/5216213/3fd4c7934d6a/crn-0008-0243-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb60/5216213/6245f0fa3fee/crn-0008-0243-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb60/5216213/3fd4c7934d6a/crn-0008-0243-g02.jpg

相似文献

1
Early Motor Fluctuations in a Patient with Striatonigral Degeneration.一名纹状体黑质变性患者的早期运动波动
Case Rep Neurol. 2016 Dec 13;8(3):243-250. doi: 10.1159/000453254. eCollection 2016 Sep-Dec.
2
Evaluation of striatonigral connectivity using probabilistic tractography in Parkinson's disease.应用概率追踪技术评估帕金森病纹状体-黑质连接。
Neuroimage Clin. 2017 Sep 9;16:557-563. doi: 10.1016/j.nicl.2017.09.009. eCollection 2017.
3
Dopamine D1 receptors in Parkinson's disease and striatonigral degeneration: a positron emission tomography study.帕金森病和纹状体黑质变性中的多巴胺D1受体:一项正电子发射断层扫描研究。
J Neurol Neurosurg Psychiatry. 1993 May;56(5):467-72. doi: 10.1136/jnnp.56.5.467.
4
[Symptomatic laterality and magnetic resonance imaging (MRI) of the putamen in striatonigral degeneration (SND)].[纹状体黑质变性(SND)中壳核的症状性偏侧性与磁共振成像(MRI)]
Rinsho Shinkeigaku. 1994 Apr;34(4):326-30.
5
[A 46-year-old man with right-side dominant parkinsonism, who suffered a sudden death].一名46岁右侧优势型帕金森病男性患者,猝死。
No To Shinkei. 1996 Nov;48(11):1059-67.
6
[Striatonigral degeneration].
Nihon Rinsho. 1997 Jan;55(1):123-6.
7
[A-56-year-old woman with parkinsonism, whose mother had Parkinson's disease].一名患有帕金森综合征的56岁女性,其母亲患有帕金森病。
No To Shinkei. 2001 May;53(5):495-505.
8
[Striatonigral degeneration and sporadic olivopontocerebellar atrophy: a consideration of the clinical entity of multiple system atrophy].[纹状体黑质变性与散发性橄榄脑桥小脑萎缩:对多系统萎缩临床实体的思考]
No To Shinkei. 1999 Apr;51(4):305-12.
9
A rat model of striatonigral degeneration generated by simultaneous injection of 6-hydroxydopamine into the medial forebrain bundle and quinolinic acid into the striatum.一种通过将6-羟基多巴胺同时注射到内侧前脑束以及将喹啉酸注射到纹状体而建立的纹状体黑质变性大鼠模型。
J Korean Med Sci. 2014 Nov;29(11):1555-61. doi: 10.3346/jkms.2014.29.11.1555. Epub 2014 Nov 4.
10
A novel grading scale for striatonigral degeneration (multiple system atrophy).一种用于纹状体黑质变性(多系统萎缩)的新型分级量表。
J Neural Transm (Vienna). 2002 Mar;109(3):307-20. doi: 10.1007/s007020200025.

本文引用的文献

1
The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease.运动障碍学会循证医学综述更新:帕金森病运动症状的治疗方法。
Mov Disord. 2011 Oct;26 Suppl 3:S2-41. doi: 10.1002/mds.23829.
2
T2*-weighted MRI in diagnosis of multiple system atrophy. A practical approach for clinicians.
J Neurol. 2007 Sep;254(9):1184-8. doi: 10.1007/s00415-006-0496-1. Epub 2007 Mar 14.
3
Motor response to levodopa and the evolution of motor fluctuations in the first decade of treatment of Parkinson's disease.帕金森病治疗最初十年中左旋多巴的运动反应及运动波动的演变
Mov Disord. 2002 Nov;17(6):1227-34. doi: 10.1002/mds.10244.
4
FLAIR MRI of striatonigral degeneration.纹状体黑质变性的液体衰减反转恢复序列磁共振成像
Neurology. 2001 May 8;56(9):1200. doi: 10.1212/wnl.56.9.1200.
5
The combination of hypointense and hyperintense signal changes on T2-weighted magnetic resonance imaging sequences: a specific marker of multiple system atrophy?T2加权磁共振成像序列上低信号和高信号变化的组合:多系统萎缩的特异性标志物?
Arch Neurol. 1999 Feb;56(2):225-8. doi: 10.1001/archneur.56.2.225.
6
Dopamine D1 and D2 receptors in Parkinson's disease and striatonigral degeneration determined by PET.通过正电子发射断层扫描(PET)测定帕金森病和纹状体黑质变性中的多巴胺D1和D2受体。
Adv Neurol. 1993;60:488-93.
7
Basic mechanisms of motor fluctuations.运动波动的基本机制。
Neurology. 1994 Jul;44(7 Suppl 6):S10-4.
8
Wearing-off fluctuations in Parkinson's disease: contribution of postsynaptic mechanisms.帕金森病中的剂末现象波动:突触后机制的作用
Ann Neurol. 1994 Jul;36(1):27-31. doi: 10.1002/ana.410360108.
9
Clinical features and natural history of multiple system atrophy. An analysis of 100 cases.多系统萎缩的临床特征与自然病史:100例分析
Brain. 1994 Aug;117 ( Pt 4):835-45. doi: 10.1093/brain/117.4.835.
10
"Pure" striatonigral degeneration and Parkinson's disease: a comparative clinical study.“纯”纹状体黑质变性与帕金森病:一项对比临床研究。
Mov Disord. 1995 May;10(3):288-94. doi: 10.1002/mds.870100310.